Cochrane Abstracts
Anti‐spasticity agents for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐spasticity Agents for Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432085/1/Anti‐spasticity_agents_for_multiple_sclerosis.
Anti‐spasticity agents for multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/1/Anti‐spasticity_agents_for_multiple_sclerosis. Accessed January 8, 2026.
Anti‐spasticity agents for multiple sclerosis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/1/Anti‐spasticity_agents_for_multiple_sclerosis
Anti‐spasticity Agents for Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/1/Anti‐spasticity_agents_for_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐spasticity agents for multiple sclerosis
ID - 432085
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/1/Anti‐spasticity_agents_for_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
